Correlation between Serum Levels of Vaspin, BMI, and Waist Circumference on Obese and Non-Obese Subjects
DOI:
https://doi.org/10.24293/ijcpml.v30i1.2097Keywords:
Obesity, non-obesity, serum levels of vaspinAbstract
Obesity is the accumulation of excessive fat resulting from an imbalance in energy intake compared to energy used for a long period. Vaspin is secreted in adipose tissue and may exhibit compensatory responses related to obesity, insulin resistance, and type 2 diabetes mellitus. This study aimed to determine vaspin levels in obese and non-obese subjects. An observational research design with a cross-sectional approach was used in this study. A total of 80 research subjects were included in this study. The research was conducted at the Clinical Pathology Laboratory at the Department of Clinical Pathology, Hasanuddin University Hospital in January 2022. Kolmogorov-Smirnov test was used to determine the normality of the data. Chi-Square, unpaired T-test, Mann-Whitney test, and Spearman test were used as statistical tests. This study showed a significant difference in anthropometric parameters between the obese and non-obese groups (p < 0.001). There was a significant difference in the mean levels of vaspin between the obese and non-obese groups (707.68±774.47 ng/mL vs. 510.60±460.08 ng/mL, p=0.004). There was a positive correlation between vaspin levels and waist circumference (r = 0.245, p=0.004) and between vaspin levels and BMI (r = 0.322, p=0.028). The serum levels of vaspin tended to be higher in obese subjects compared to non-obese subjects. The positive correlation between vaspin levels and BMI and waist circumference indicated that a higher BMI and/or waist circumference led to a higher vaspin level.
Downloads
References
World Health Organization (WHO). Obesity and overweight [Internet]. Global Health Observatory (GHO). 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed Aug 19, 2021).
Omer T. The causes of obesity: An in-depth review. Adv Obesity, Weight Manag Control, 2020; 10(4): 90–4.
Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract, 2017; 29: S3–14.
Harbuwono DS, Pramono LA, Yunir E, Subekti I. Obesity and central obesity in Indonesia: Evidence from a national health survey. Med J Indones. 2018; 27(2): 53–9.
Escote X, Gomez-Zorita S, Lopez-Yoldi M, Milton-Laskibar I, Fernandez- Quintela A, et al. Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development. Int J Mol Sci, 2017; 18(8): 1–27.
Watanabe T, Watanabe-Kominato K, Takahashi Y, Kojima M, Watanabe R. Adipose tissue-derived omentin-1 function and regulation. Compr Physiol, 2017; 7(3): 765–81.
Pilarski L, Pelczynska M, Koperska A, Seraszek-Jaros A, Szulinska M, Bogdanski P. Association of serum vaspin concentration with metabolic disorders in obese individuals. Biomolecules, 2023; 13(3): 508.
Yin C, Hu W, Wang M, Xiao Y. The role of the adipocytokines vaspin and visfatin in vascular endothelial function and insulin resistance in obese children. BMC Endocr Disord, 2019. Available from: https://doi.org/10.1186/s12902-019-0452-6 (accessed Aug 19, 2021).
Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES. Serum vaspin concentrations in human obesity and type 2 diabetes. National Library of Medicine, 2017; 57(2): 372–7.
Jung HN, Jung CH. The role of anti-inflammatory adipokines in cardiometabolic disorders: Moving beyond adiponectin. Int. J. Mol. Sci, 2021; 22: 13529.
Kim KB, Shin YA. Males with obesity and overweight. J Obes Metabolic Syndrome, 2020; 29 (1): 18-25.
Anakok GA, Awad SF, Çaglayan Ç, Huangfu P, Raddad L, et al. Impact of trends and gender disparity in obesity on future type 2 diabetes in Turkey: A mathematical modelling analysis. BMJ Open, 2022; 12: e053541.
Anna Nordstrom, Jenny Hadrevi, Tommy Olsson, Paul W Franks, Peter Nordstrom. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. The Journal of Clinical Endocrinology & Metabolism, 2016; 101(10): 3740–3746.
Dwipayana IMP, Semadi IMS, Gotera W, Saraswati MR, Suastika K. Vaspin in developing obesity (Vande-Ob); The correlation of waist circumference and visceral fat percentage with vaspin levels in patients with type II diabetes mellitus. Open Access Maced J Med Sci, 2019; 7(1): 50-52.
Piqueras P, Ballester A, Dura-Gil JV, Martinez-Hervas S, Redon J, Real JT. Anthropometric indicators as a tool for diagnosis of obesity and other health risk factors: A literature review. Front Psychol, 2021; 12: 631179.
Ertekin H, Uysal S, Aydin M, Ilham B, Ertekin HY. Correlation between vaspin and PANSS score in schizophrenia patient with obesity. The International Journal of Psychiatry in Medicine, 2020; 1: 1-17.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
